Manuel Comabella

Has grant

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Los astrocitos como diana en la prevención de la neurodegeneración en pacientes con esclerosis múltiple

Open Date: 2016-01-01

Close Date: 2018-12-31

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Luisa María Villar

Universidad de Alcalá

SPAIN

View details

Jan Lunemann

Professor

University of Münster

GERMANY

View details

Rucsanda Pinteac

Vall d'Hebron Institut de Recerca

SPAIN

View details

Maria Buxó Pujolràs

Institut de Recerca Biomèdica de Lleida

SPAIN

View details

Alessandro Dinoto

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

Alex Sánchez-Pla

Professor

University of Barcelona

SPAIN

View details

jose m lizcano

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Jose L. Luque-Garcia

Assistant Professor

Universidad Complutense de Madrid

SPAIN

View details

Amit Bar-Or

Professor

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manuel Comabella

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (18)

Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis

Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile

Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study

Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis

Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients

Cytomegalovirus immune responses are associated with lower serum NfL and disability accumulation risk at multiple sclerosis onset

Chitinase 3‐like 1 is neurotoxic in multiple sclerosis patient‐derived cortical neurons

Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies

Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis

Liquid Biopsy in Neurological Diseases

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure

MOG antibodies in adults with a first demyelinating event suggestive of multiple sclerosis

Serum neurofilament light chain levels predict long-term disability progression in patients with progressive multiple sclerosis

Targeting Inflammasomes to Treat Neurological Diseases

Immunomodulatory Effects Associated with Cladribine Treatment

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis

Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers

Collaborators (9)

Luisa María Villar

Jan Lunemann

Rucsanda Pinteac

Maria Buxó Pujolràs

Alessandro Dinoto

Alex Sánchez-Pla

jose m lizcano

Jose L. Luque-Garcia

Amit Bar-Or

Make your next move.